RTS AND ITS ROLE IN CHEMOTHERAPY
RTS AND ITS ROLE IN CHEMOTHERAPY
批准号:
2837666
负责人:
BRUCE JEFFREY DOLNICK
金额:
$14.73万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-07-01 至 2000-11-30
关键词:
中文摘要
描述:(申请人摘要)本申请的长期目标
英文摘要
DESCRIPTION: (Applicant's Abstract) The long-term goal of this application
is to determine the physiologic function of the rTS gene and its relevance
to cancer therapeutics. rTS is a gene which overlaps the human thymidylate
synthase (TS) gene and is encoded by the opposite strand of DNA. rTS is
transcribed so as to produce one RNA (rTS-alpha) which is complementary to
TS and to another, rTS-beta, which is not. The rTS gene codes for at least
two proteins, rTS-alpha and rTS-beta. rTSB has been found to be
overexpressed in three cell lines resistant to: 5-fluorouracil (H630-1,
colon cancer), methotrexate (K562 B1A, chronic myelogenous leukemia and
fluorodeoxyuridine plus ZD 1694 (HCT-8DF2, ileocecal carcinoma). Elevation
of rTSB protein levels in the methotrexate-resistant, and fluorodeoxyuridine
plus ZD 1694 cell lines are accompanied, respectively, by a complete and
partial loss of growth regulation of TS activity. rTSB protein levels also
increase as cells progress from log to stationary phase growth.
Immunoprecipitation data indicate that rTSB, and a newly discovered protein,
rTS, are complexed with TS and dihydrofolate reductase (DHFR). Taken
together, the applicant has presented substantial preliminary data that
suggest that rTS proteins appear to play a role in growth regulation of TS
and in the development of cellular drug resistance. Four specific aims are
proposed to investigate how rTS may impact on TS gene expression, cellular
physiology, and sensitivity to TS inhibitors. They are as follows: 1)
Extended characterization of rTS protein expression and identification of
and subcellular localization of complex formation of rTS proteins with TS
and DHFR, respectively, as a function of growth; 2) Effect of altered
expression of rTS-alpha and rTS-beta in transfected human cancer cells on
properties of cell growth, TS enzyme activity and TS protein expression,
formation of rTS:TS complex and subsequent sensitivity of cancer cells to TS
inhibitors; 3) Expression and purification of rTS-beta and rTS-alpha from
Pichia pastoris and to determine the effects of purified rTS protein on TS
and DHFR enzyme activity and on sensitivity to TS inhibitors in vitro; and
4) Mapping and cloning of the rTS gene in order to characterize the rTS gene
structure and organization.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
Subclonal heterogeneity of the multidrug resistance phenotype in a cell line expressing antisense MDR1 RNA.
表达反义 MDR1 RNA 的细胞系中多药耐药表型的亚克隆异质性。
DOI:
10.1007/bf02255838
发表时间:
1994
期刊:
Somatic cell and molecular genetics
影响因子:
--
作者:
[Hanchett,LA, Baker,RM, Dolnick,BJ]
通讯作者:
Dolnick,BJ
Expression of rTS correlates with altered growth regulation of thymidylate synthase.
rTS 的表达与胸苷酸合酶生长调节的改变相关。
DOI:
--
发表时间:
1996
期刊:
Cancer research.
影响因子:
--
作者:
[Black,AR, Dolnick,BJ]
通讯作者:
Dolnick,BJ
Alternate splicing of the rTS gene product and its overexpression in a 5-fluorouracil-resistant cell line.
rTS 基因产物的交替剪接及其在 5-氟尿嘧啶抗性细胞系中的过度表达。
DOI:
--
发表时间:
1996
期刊:
Cancer research.
影响因子:
--
作者:
[Dolnick,BJ, Black,AR]
通讯作者:
Black,AR
Validation of rTS as a Molecular Target
-
批准号:6515047
-
项目类别:
-
资助金额:$16.72万
-
财政年份:2001
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
Validation of rTS as a Molecular Target
-
批准号:6334042
-
项目类别:
-
资助金额:$16.53万
-
财政年份:2001
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
QUORUM SENSING IN HUMAN CELLS
-
批准号:6377966
-
项目类别:
-
资助金额:$23.09万
-
财政年份:2000
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
QUORUM SENSING IN HUMAN CELLS
-
批准号:6159431
-
项目类别:
-
资助金额:$23.09万
-
财政年份:2000
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
QUORUM SENSING IN HUMAN CELLS
-
批准号:6514606
-
项目类别:
-
资助金额:$23.09万
-
财政年份:2000
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
QUORUM SENSING IN HUMAN CELLS
-
批准号:6610990
-
项目类别:
-
资助金额:$23.09万
-
财政年份:2000
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
EDITING OF THYMIDYLATE SYNTHASE RNA
-
批准号:6497524
-
项目类别:
-
资助金额:$23.56万
-
财政年份:1999
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
EDITING OF THYMIDYLATE SYNTHASE RNA
-
批准号:6350349
-
项目类别:
-
资助金额:$22.99万
-
财政年份:1999
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
EDITING OF THYMIDYLATE SYNTHASE RNA
-
批准号:2806096
-
项目类别:
-
资助金额:$17.18万
-
财政年份:1999
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
EDITING OF THYMIDYLATE SYNTHASE RNA
-
批准号:6150367
-
项目类别:
-
资助金额:$20.48万
-
财政年份:1999
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
ANTISENSE SUPPRESSION OF MDRL GENE EXPRESSION
-
批准号:6236035
-
项目类别:
-
资助金额:$0.83万
-
财政年份:1994
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
HUMAN THYMIDYLATE SYNTHASE ANTISENSE RNA
-
批准号:3201987
-
项目类别:
-
资助金额:$12.59万
-
财政年份:1992
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
HUMAN THYMIDYLATE SYNTHASE ANTISENSE RNA
-
批准号:2098374
-
项目类别:
-
资助金额:$13.53万
-
财政年份:1992
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
RTS AND ITS ROLE IN CHEMOTHERAPY
-
批准号:2008111
-
项目类别:
-
资助金额:$14.19万
-
财政年份:1992
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
RTS AND ITS ROLE IN CHEMOTHERAPY
-
批准号:2608094
-
项目类别:
-
资助金额:$14.3万
-
财政年份:1992
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
HUMAN THYMIDYLATE SYNTHASE ANTISENSE RNA
-
批准号:3201988
-
项目类别:
-
资助金额:$13.43万
-
财政年份:1992
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
ANTISENSE AS AN APPROACH TO CANCER CHEMOTHERAPY
-
批准号:3193028
-
项目类别:
-
资助金额:$9.76万
-
财政年份:1988
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
EFFECTS OF ANTIMETABOLITES ON RNA METABOLISM
-
批准号:3172017
-
项目类别:
-
资助金额:$12.11万
-
财政年份:1988
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
ANTISENSE AS AN APPROACH TO CANCER CHEMOTHERAPY
-
批准号:3193029
-
项目类别:
-
资助金额:$8.92万
-
财政年份:1988
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
EFFECTS OF ANTIMETABOLITES ON RNA METABOLISM
-
批准号:3172016
-
项目类别:
-
资助金额:$7.9万
-
财政年份:1988
-
负责人:BRUCE JEFFREY DOLNICK
-
依托单位:
海外基金